Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or call +44 (0)1344 864796.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? You can contact our Delegate Relations team at delegate.relations@forumsupport.co.uk or by calling the above number.

Priorities for diagnostics and medical technology - regulation, supporting research and innovation, optimising services and addressing waiting times

Morning, Tuesday, 1st March 2022


This conference will examine what is needed for improving diagnostic speed and outcomes - as well as looking at the next steps for regulating medical technology and supporting continued research and innovation post-Brexit.


It will also be an opportunity to discuss the future outlook for medical device regulation in the wake of Brexit as the MHRA consults on a more transparent and flexible approach.


The conference takes place as the Government launches funding and strategic plans to support innovation and build on the achievements of the life sciences sector, including the announcement of £248m for the NHS to invest in modernising diagnostics as part of wider efforts to address waiting lists.


We are very pleased to be able to include keynote sessions with:

  • Professor Sir Mark Caulfield, Professor of Clinical Pharmacology, Queen Mary University of London, Chief Executive Officer, Barts Life Sciences; and lately Chief Scientist at Genomics England
  • Dr Sarah Byron, Programme Director, Centre for Health Technology Evaluation, NICE
  • Professor Louise Jones, Chair, Genomics and Reproductive Science Specialty Advisory Committee, Royal College of Pathologists; and Professor of Breast Pathology, Barts Cancer Institute
  • Stephen Lee, Director, Diagnostics Regulation, Association of British Healthcare Industries
  • Dr Michael Messenger, Principal Scientific Advisor for In Vitro Diagnostics, MHRA
  • Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association

The discussion is bringing together stakeholders with key policy officials who are due to attend from the DHSC; the DIT; the MHRA; The Scottish Government; and the Welsh Government - as well as parliamentary pass-holders from the House of Lords.



Keynote Speakers

Stephen Lee

Director, Diagnostics Regulation, Association of British Healthcare Industries

Professor Sir Mark Caulfield

Professor of Clinical Pharmacology, Queen Mary University of London; and Chief Executive Officer, Barts Life Sciences; and former Chief Scientist, Genomics England

Keynote Speakers

Professor Sir Mark Caulfield

Professor of Clinical Pharmacology, Queen Mary University of London; and Chief Executive Officer, Barts Life Sciences; and former Chief Scientist, Genomics England

Professor Michael Messenger

Principal Scientific Advisor for In Vitro Diagnostics, MHRA

Professor Louise Jones

Chair, Genomics, and Reproductive Science Specialty Advisory Committee, Royal College of Pathologists; and Professor of Breast Pathology, Barts Cancer Institute

Stephen Lee

Director, Diagnostics Regulation, Association of British Healthcare Industries

Doris-Ann Williams

Chief Executive, British In Vitro Diagnostics Association

Dr Sarah Byron

Programme Director, Centre for Health Technology Evaluation, NICE

Chair

Anne Marie Morris MP

Chair, Access to Medicines and Medical Devices All-Party Parliamentary Group

Speakers

Hadleigh Stollar

Chief Executive, Healthcare Innovation Consortium

Mike Moran

Chief Executive, Rutherford Health

Shuna Mason

Partner, CMS UK Lifesciences Division

Professor Alastair Denniston

Director, INSIGHT, Health Data Research UK; Consultant Ophthalmologist, Research and Innovation, University Hospitals Birmingham NHSFT; and Deputy Director, Birmingham Health Partners Centre for Regulatory Science and Innovation

Professor Mark Lawler

Associate Pro-Vice-Chancellor and Professor of Digital Health Faculty of Medicine, Health and Life Sciences/ Scientific Director, Queen’s University Belfast/ DATA-CAN

Wil Woan

Chief Executive, Heart Valve Voice